Search publications

Reset filters Search by keyword

No publications found.

 

A Spike-Accum bioconjugate protein vaccine confers potent SARS-CoV-2-specific immunity

Author(s): Pierre Bikorimana J; Caveney NA; El-Hachem N; Mandl GA; Capobianco JA; Stanga D; Abusarah J; Hancock MA; Farah R; Gonçalves MP; Falzarano D; Liao M; Hamonic G; Liu Q; Beaudoin S; Talbot S; Rafei M;

Despite the recent control of COVID-19, the devastating effects caused by the 3-year pandemic highlight the importance of developing effective vaccines to rapidly address future outbreaks. The present study describes a novel Spike (Sp) protein-based vaccine formulation using the Accum platform. A ...

Article GUID: 41054531


-   Page 1 / 1   -